Primary Normal Human Cells And Media: In Vivo Relevance. In Vitro Results.

Advancing gene therapy and drug discovery requires cell models that accurately reflect human biology. Standardized cell lines often fail to capture the complex physiological responses found in vivo, leading to discrepancies during discovery and validation. Utilizing primary human cells provides a more reliable bridge between laboratory research and clinical application, offering the phenotypic relevance necessary to evaluate safety and efficacy with higher precision.

A comprehensive inventory of primary cells — ranging from airway epithelial and specialized endothelial to hematopoietic cells like CD34+ and NK cells — enables researchers to tailor their assays to specific therapeutic targets. Supporting these cells with optimized, serum-free growth media ensures consistent performance and viability in culture. By integrating primary cells into your workflows, you can enhance the predictability of your discovery process and accelerate the path to the clinic.